↓ Skip to main content

Oral Bisphosphonate Use and Risk of Postmenopausal Endometrial Cancer

Overview of attention for article published in Journal of Clinical Oncology, February 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
4 news outlets
twitter
19 X users
facebook
4 Facebook pages
guideline
1 clinical guideline source

Readers on

mendeley
42 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Oral Bisphosphonate Use and Risk of Postmenopausal Endometrial Cancer
Published in
Journal of Clinical Oncology, February 2015
DOI 10.1200/jco.2014.58.6842
Pubmed ID
Authors
Abstract

Bisphosphonates are common medications used for the treatment of osteoporosis and are also used to reduce metastases to bone in patients with cancer. Several studies, including the Women's Health Initiative (WHI), have found that use of bisphosphonates is associated with reduced risk of developing breast cancer, but less is known about associations with other common malignancies. This study was aimed at examining the effects of bisphosphonates on the risk of endometrial cancer.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 42 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 11 26%
Student > Ph. D. Student 5 12%
Student > Bachelor 4 10%
Student > Doctoral Student 3 7%
Student > Master 2 5%
Other 4 10%
Unknown 13 31%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 18 43%
Nursing and Health Professions 3 7%
Agricultural and Biological Sciences 3 7%
Biochemistry, Genetics and Molecular Biology 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 1 2%
Unknown 14 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 42. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2017.
All research outputs
#1,248,490
of 34,457,357 outputs
Outputs from Journal of Clinical Oncology
#3,327
of 32,389 outputs
Outputs of similar age
#12,582
of 295,766 outputs
Outputs of similar age from Journal of Clinical Oncology
#50
of 259 outputs
Altmetric has tracked 34,457,357 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,389 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.5. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 295,766 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 259 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.